Skip to main content

Client News

Abivax releases the results of its June 5, 2023 ordinary and extraordinary general meeting

6th June 2023

Carbios aims to be a leader in growing r-PET market with an ambition to capture 8 to 12% share by 2035 through licensing model

6th June 2023

Secarna Pharmaceuticals announces publication of new preclinical data showing durable antitumor activity of LNAplus™-based ASOs that both stimulate the innate immune system and suppress PD-L1 expression

5th June 2023

Element Materials creates a new Lab Solutions division within Life Sciences, providing advanced equipment for laboratories

5th June 2023

Carbios and Indorama Ventures reaffirm partnership to build first-of-a-kind PET biorecycling plant in France

1st June 2023

Medigene AG: Medigene Announces Pipeline Expansion into Neoantigens with Programs Targeting Multiple KRAS Mutations and HLAs

1st June 2023

Rentschler Biopharma joins forces with Ikarovec to accelerate novel gene therapies for treatment of ophthalmic disease

1st June 2023

Apogenix’ new CD40 agonist HERA-CD40L significantly reduces tumor growth in prostate cancer model compared to 8.2 % in institutional database with asunercept plus standard of care in newly diagnosed glioblastoma multiforme patients

1st June 2023

Carbios will receive grants totaling €54 million from French State via France 2030 and Grand-Est Region[1] to finance construction of world’s first PET biorecycling plant and accelerate R&D activities

31st May 2023

Mainz Biomed Expands Commercial Footprint into Poland

31st May 2023